The management of intraocular retinoblastoma is rapidly changing, and even recent reviews
on the subject are behind existing practices. The 4 authors of this report collectively
represent their management strategies with an emphasis on areas of agreement and
disagreement. Ophthalmic artery chemosurgery and intravitreous chemotherapy have
completely replaced external beam radiotherapy, reduced the use of systemic
chemotherapy, and diminished enucleations by 90% without evidence of compromising …